Evidence map›Paper›PMID 15516470›Full record

ArticleThorax2004

Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe.

T Coenye, T Spilker, A Van Schoor, J J LiPuma, P Vandamme

Open access · bronzeAbstract read
In one paragraph

Article in Thorax, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  9. Host evasion by Burkholderia cenocepacia.Frontiers in cellular and infection microbiology · 2011
    Review
  10. The changing microbial epidemiology in cystic fibrosis.Clinical microbiology reviews · 2010
    Review
  11. Biocide susceptibility of the Burkholderia cepacia complex.The Journal of antimicrobial chemotherapy · 2009
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T CoenyeLaboratory of Microbiology, Ghent University, Ghent, Belgium. Tom.Coenye@ugent.be
T Spilker
A Van Schoor
J J LiPuma
P Vandamme
Ghent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBurkholderia cenocepacia can cause life threatening respiratory tract infections in patients with cystic fibrosis (CF) and has a significant impact on survival. There is extensive evidence for patient to patient spread and nosocomial transmission of this organism, and several widespread B cenocepacia strains have been described including the transatlantic ET12 clone. A study was performed to compare B cenocepacia isolates recovered from CF patients receiving care in several European countries and strains isolated from other clinical samples and the environment, with reference isolates from the epidemic B cenocepacia strain PHDC which has so far only been recovered from CF patients and soil in the USA.

methodsA large collection of B cenocepacia isolates, including a large number recovered from CF patients receiving care in several European countries, Canada and the USA, were genotyped by means of randomly amplified polymorphic DNA typing (RAPD) and rep-PCR using the BOX-A1R primer (BOX-PCR).

resultsNineteen Burkholderia cenocepacia isolates cultured from clinical samples in Europe (18 recently recovered from CF patients in France and Italy and one recovered in 1964 from urine in the UK) showed RAPD fingerprinting patterns that were similar to patterns obtained from isolates of B cenocepacia strain PHDC. Subsequent analysis of these isolates using BOX-PCR confirmed that the European isolates and strain PHDC represent the same clone.

conclusionStrain PHDC represents a second transatlantic B cenocepacia clone capable of colonising patients with CF.

Indexed as

Bacterial Typing TechniquesBurkholderia cepaciaBurkholderia InfectionsCystic FibrosisEuropeGenotypeHumansPolymerase Chain Reaction

Identifiers

PMID15516470
PMCPMC1746878
OpenAlexW2103244869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.